Author

Dina Awartani

Sidra Medical and Research CenterORCID 0000-0003-4880-1301Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Ayesha JabeeniD· 1 shared Ayman SalehiD· 1 shared Christophe Michel RaynaudiD· 1 shared Eiman I. AhmediD· 1 shared Rania AlananyiD· 1 shared Shimaa SherifiD· 1 shared Wouter HendrickxiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ayesha JabeenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBritish Journal of CancerPeer-reviewedSep 2, 2026

SLFN11 Enhances Cisplatin Sensitivity in Pediatric Cancer via Activation of Stress-Response and Suppression of Survival Pathways

Ayesha Jabeen, Dina Awartani, Shimaa Sherif…·Christophe Michel Raynaud

This study shows SLFN11 enhances cisplatin sensitivity in pediatric cancers by modulating stress-response and survival pathways through epigenetic regulation and functional assays.

DOI 10.1038/s41416-026-03571-2

humanbulk RNA-seq

𝕏 PostBluesky